129 related articles for article (PubMed ID: 6287663)
1. Phosphoinositide metabolism in human blood platelets: effects of two types of divalent cation chelators.
Best L; Bone EA; Russell RG
Thromb Res; 1982 May; 26(4):241-7. PubMed ID: 6287663
[TBL] [Abstract][Full Text] [Related]
2. Platelet membrane molecular organization: relationship with membrane bound calcium.
Rendu F; Viret J; Daveloose D; Levy-Toledano S; Leterrier F
Biochem Biophys Res Commun; 1985 Feb; 126(3):1048-53. PubMed ID: 2983699
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine kinases and phosphoinositide metabolism in thrombin-stimulated human platelets.
Guinebault C; Payrastre B; Sultan C; Mauco G; Breton M; Levy-Toledano S; Plantavid M; Chap H
Biochem J; 1993 Jun; 292 ( Pt 3)(Pt 3):851-6. PubMed ID: 8391259
[TBL] [Abstract][Full Text] [Related]
4. Neomycin cannot be used as a selective inhibitor of inositol phospholipid hydrolysis in intact or semi-permeabilized human platelets. Aminoglycosides activate semi-permeabilized platelets.
Polascik T; Godfrey PP; Watson SP
Biochem J; 1987 May; 243(3):815-9. PubMed ID: 3663101
[TBL] [Abstract][Full Text] [Related]
5. Neomycin inhibits agonist-stimulated polyphosphoinositide metabolism and responses in human platelets.
Tysnes OB; Verhoeven AJ; Holmsen H
Biochem Biophys Res Commun; 1987 Apr; 144(1):454-62. PubMed ID: 3034251
[TBL] [Abstract][Full Text] [Related]
6. Neomycin inhibits platelet functions and inositol phospholipid metabolism upon stimulation with thrombin, but not with ionomycin or 12-O-tetradecanoyl-phorbol 13-acetate.
Tysnes OB; Steen VM; Holmsen H
Eur J Biochem; 1988 Oct; 177(1):219-23. PubMed ID: 2846297
[TBL] [Abstract][Full Text] [Related]
7. A new congenital defect of platelet secretion: impaired responsiveness of the platelets to cytoplasmic free calcium.
Hardisty RM; Machin SJ; Nokes TJ; Rink TJ; Smith SW
Br J Haematol; 1983 Apr; 53(4):543-57. PubMed ID: 6830700
[TBL] [Abstract][Full Text] [Related]
8. The rapid PI-turnover is not coupled with the aggregation in A23187-activated human platelets.
Imai A; Nozawa Y
Biochem Biophys Res Commun; 1982 Mar; 105(1):236-43. PubMed ID: 6807299
[No Abstract] [Full Text] [Related]
9. PDGF modifies phosphoinositide metabolism and inhibits aggregation and release in human platelets.
Bryckaert MC; Rendu F; Tobelem G; Caen J
Biochem Biophys Res Commun; 1986 Feb; 135(1):52-7. PubMed ID: 3006686
[TBL] [Abstract][Full Text] [Related]
10. Serotonin release and phosphoinositide breakdown in thrombin-induced activation of human platelets.
Marche P; Rendu F; Maclouf J; Girard A; Levy-Toledano S
J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S18-9. PubMed ID: 2412047
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the inhibition of U46619-mediated human platelet activation by the trimetoquinol isomers. Evidence for endoperoxide/thromboxane A2 receptor blockade.
Ahn CH; Romstedt KJ; Wallace LJ; Miller DD; Feller DR
Biochem Pharmacol; 1988 Aug; 37(15):3023-33. PubMed ID: 3134894
[TBL] [Abstract][Full Text] [Related]
12. A diacylglycerol kinase inhibitor, R59022, potentiates secretion by and aggregation of thrombin-stimulated human platelets.
Nunn DL; Watson SP
Biochem J; 1987 May; 243(3):809-13. PubMed ID: 2821994
[TBL] [Abstract][Full Text] [Related]
13. Evidence that the platelet plasma membrane is impermeable to calcium and magnesium complexes of A23187. A23187-induced secretion is inhibited by MG2+ and Ca2+, and requires aggregation and active cyclooxygenase.
Holmsen H; Dangelmaier CA
J Biol Chem; 1981 Oct; 256(20):10449-52. PubMed ID: 6793580
[TBL] [Abstract][Full Text] [Related]
14. Thrombin induces serotonin secretion and aggregation independently of inositol phospholipids hydrolysis and protein phosphorylation in human platelets permeabilized with saponin.
Lapetina EG; Silió J; Ruggiero M
J Biol Chem; 1985 Jun; 260(11):7078-83. PubMed ID: 2987242
[TBL] [Abstract][Full Text] [Related]
15. Ionophore A23187 induces a refractory state in thrombin-activated release of inositol phosphates.
Moscat G; Moreno F; Iglesias S; Garcia-Barreno P; Municio AM
Biochem J; 1986 Sep; 238(3):709-14. PubMed ID: 3099773
[TBL] [Abstract][Full Text] [Related]
16. Platelet protein phosphorylation, elevation of cytosolic calcium, and inositol phospholipid breakdown in platelet activation induced by plasmin.
Schafer AI; Maas AK; Ware JA; Johnson PC; Rittenhouse SE; Salzman EW
J Clin Invest; 1986 Jul; 78(1):73-9. PubMed ID: 3013942
[TBL] [Abstract][Full Text] [Related]
17. Molecular membrane organization in normal and pathological platelets: changes in inositide metabolism and membrane fluidity.
Rendu F; Marche P; Viret J; Daveloose D; Leterrier F; Levy-Toledano S; Caen JP
Nouv Rev Fr Hematol (1978); 1985; 27(4):293-7. PubMed ID: 2997707
[TBL] [Abstract][Full Text] [Related]
18. The inflammatory and tumor-promoting sesquiterpene lactone, thapsigargin, activates platelets by selective mobilization of calcium as shown by protein phosphorylations.
Thastrup O; Linnebjerg H; Bjerrum PJ; Knudsen JB; Christensen SB
Biochim Biophys Acta; 1987 Jan; 927(1):65-73. PubMed ID: 3098302
[TBL] [Abstract][Full Text] [Related]
19. Synergism between thrombin and adrenaline (epinephrine) in human platelets. Marked potentiation of inositol phospholipid metabolism.
Steen VM; Tysnes OB; Holmsen H
Biochem J; 1988 Jul; 253(2):581-6. PubMed ID: 2845924
[TBL] [Abstract][Full Text] [Related]
20. Relationship between intracellular calcium-dependent process and protein-tyrosine phosphorylation in human platelets: studies of platelets from a patient with defective A23187-induced platelet aggregation.
Fuse I; Higuchi W; Uesugi Y; Hattori A; Aizawa Y
Clin Lab Haematol; 1999 Feb; 21(1):29-32. PubMed ID: 10197260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
